Skip to main content
SpringerLink
Log in

Klinische Evaluation des neuen ACE-Hemmers Moexipril in der Behandlung der arteriellen Hypertonie

  • Conference paper
Bluthochdruck nach der Menopause

  • 23 Accesses

Zusammenfassung

Bei einer großen Anzahl von Patienten mit primärer Hypertonie stellt das Renin-Angiotensin-System (RAS) einen wichtigen Faktor in der Entwicklung und Aufrechterhaltung des erhöhten Blutdrucks dar. Es ist daher nicht erstaunlich, daß sich die pharmakologische Hemmung des RAS als ein effektives Wirkprinzip in der Behandlung der Hypertonie erwiesen hat [1]. Als erste, das RAS spezifisch hemmende Substanzklasse wurden die ACE-Hemmer entwickelt. Deren Effektivität ist mittlerweile nicht nur zur Behandlung der arteriellen Hypertonie, sondern auch zur Behandlung der chronischen Herzinsuffizienz und zur Behandlung der diabetischen Nephropathie erwiesen [2–4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Stimpel M (1996) Inhibitors of the renin-angiotensin system. In: Stimpel M. Arterial hypertension. Walter de Gruyter, Berlin New York, pp 241–251

    Google Scholar 

  2. The CONSENSUS Study Trial Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the North Scandinavian enalapril survival study (CONSENSUS). N Engl J Med 316: 1429–1435

    Article  Google Scholar 

  3. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced ventricular ejection fraction and congestive heart failure. N Engl J Med 325: 293–302

    Article  Google Scholar 

  4. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting- enzyme inhibition on diabetic nephropathy. N Engl J Med 329 (20): 1456–1462

    Article  PubMed  CAS  Google Scholar 

  5. Schneider-Manuskript

    Google Scholar 

  6. Bafour JA, Goa KL (1991) Benazepril: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure. Drugs 42: 511–539

    Google Scholar 

  7. Singhvi SM, Duchin KL, Morrison RA, Willard DA, Everett DW, Frantz M (1988) Disposition of fosinopril sodium in healthy subjects. Br J Clin Pharmacol 25: 9–15

    PubMed  CAS  Google Scholar 

  8. Lancaster SG, Todd PA (1995) Lisinopril a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hyptertension and congestive heart failure. Drugs 35: 646–669

    Article  Google Scholar 

  9. Stimpel M, Cawello W (1995) Pharmacokinetics and ACE-inhibition of the new ACE-inhi- bitor moexipril: Is Coadministration with food of clinical relevance? Hyptertension 26: 1384

    Google Scholar 

  10. Hui KK, Duchin KL, Kripalani KJ, Chan D, Kramer PK, Yanagawa N (1991) Pharmacokinetics of fosinopril in patients with various degress of renal function. Clin Pharmacol Ther 49: 457–467

    Article  PubMed  CAS  Google Scholar 

  11. Todd PA, Benfield P (1990) Ramipril: a review of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 39: 110–135

    Article  PubMed  CAS  Google Scholar 

  12. Drayer JI, Stimpel M, Fox AAL, Weber MA (1995) The antihypertensive properties of the angiotensin converting inhibitor moexipril given alone or in combination wit a low dose of a diuretic. Am J Therap 2: 525–531

    Article  Google Scholar 

  13. Persson B, Stimpel M (1996) Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients. Eu- rop J Clin Pharmacol 50: 259–264

    Article  CAS  Google Scholar 

  14. Mroczek WJ, Stimpel M (1996) A double-blind evaluation of moexipril versus hydrochlorothiazide in hypertension. Adv Ther 13: 79–87

    Google Scholar 

  15. Lucas CP, Darga LL, Fox AAL, Stimpel M (1995) A study of the efficacy and safety of moexipril in mild to moderate hypertension. Am J Therap 2: 886–892

    Article  Google Scholar 

  16. White WB, Whelton A, Fox AAL, Stimpel M, Kaihlanen PM (1995) Tri-center assessment of the efficacy and pharmacodynamics of the ACE inhibitor moexipril, by ambulatory blood pressure monitoring. J Clin Pharmacol 35: 233–238

    PubMed  CAS  Google Scholar 

  17. Koch B, Stimpel M, Andersson O (1995) Low-dose combinations of moexipril and hydrochlorothiazide in the treatment of hyptertension. Pharmacol Res 31 (suppl): 322

    Article  Google Scholar 

  18. Dickstein K, Aarsland T, Ferrari P, Todd M, Stimpel M (1994) Comparison of the efficacy of three dose levels of moexipril versus placebo as add-on therapy to hydrochlorothiazide in patients with moderate hypertension. J Cardiovasc Pharmacol 24: 247–255

    PubMed  CAS  Google Scholar 

  19. Persson B, Widgren BR, Fox AAL, Stimpel M (1995) Antihypertensive effects of moexipril, a new ACE inhibitor, as add on therapy to nifedipine in patients with essential hypertension. J Cardiovasc Pharmacol 26: 73–78

    Article  PubMed  CAS  Google Scholar 

  20. Stimpel M, Loh IK (1996) Moexipril versus Captopril in patients with mild to moderate hypertension. J Cardiovasc Pharmacol 28: 769–773

    Article  PubMed  CAS  Google Scholar 

  21. Abernethy DR, Fox AAL, Stimpel M (1995) Moexipril in the treatment of mild to moderate essential hypertension: comparison with sustained release verapamil. Clin Pharmacol 35: 795–799

    Google Scholar 

  22. White WB, Koch B, Stimpel M (1997) Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension. Am J Therap 4: 123–129

    Article  CAS  Google Scholar 

  23. Chrysant SG, Koch B, Stimpel M (1998) Antihypertensive effectiveness of a very low fixed- dose combination of moexipril and hydrochlorothiazide. J Cardiovasc Pharmacol 31:384– 390

    Google Scholar 

  24. White WB, Fox AAL, Stimpel M (1994) Long-term efficacy and safety of moexipril in the treatment of hypertension. J Hum Hypertens 8: 917–921

    PubMed  CAS  Google Scholar 

  25. White WB, Stimpel M (1995) Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension. J Hum Hypertens 9: 879–884

    PubMed  CAS  Google Scholar 

  26. Chrysant SG, Fox AAL, Stimpel M (1995) Comparison of moexipril - a novel ACE-inhibi- tor - to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients. Am J Hypertens 8: 418–421

    Article  PubMed  CAS  Google Scholar 

  27. Saunders E, Weir MR, Kong W, Hollifield J, Gray et al. (1990) A comparison of the efficacy and safety of a alpha-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 150: 1707–1713

    Article  PubMed  CAS  Google Scholar 

  28. Girard M (1991) The safety of angiotensin-converting enzyme (ACE) inhibitors in moderate hypertension. Adverse Drug React Toxicol Rev 10: 169–185

    PubMed  CAS  Google Scholar 

  29. Parish RC, Miller LJ (1992) Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update. Drug Safety 7: 14–31

    Google Scholar 

  30. Heel RC, Brogden RN, Speight TM, Avery GS (1980) Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs 20: 409–452

    Article  PubMed  CAS  Google Scholar 

  31. Brunner HR, Waeber B, Nussberger J (1996) Angiotensin-converting enzyme inhibitors in arterial hypertension. In: Messerli FH (ed) Cardiovascular Drug Therapy, 2 nd edition. Philadelphia: Saunders WB, 690–711

    Google Scholar 

  32. Stimpel M, Jee WSS, Ma Y, Yamamoto N, Chen Y (1995) Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitors moexipril, 17–P-estradiol and their combination of the ovariectomy-induced cancellous bone loss in young rats. J Hypertens 13: 1852–1856

    Article  PubMed  CAS  Google Scholar 

  33. Ma YF, Stimpel M, Liang H, Pun S, Jee WSS (1997) Impact of antihypertensive therapy on skeleton: effects of moexipril and hydrochlorothiazide on ovariectomized osteopenia in spontaneously hypertensive rats. J Endocrinol 154: 467–474

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A.-L. Schiemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Stimpel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinischen Poliklinik, Humboldt-Universität - Charité, Luisenstr. 11-13A, 10117, Berlin, Deutschland

    Jürgen Scholze (Direktor) (Direktor)

  2. ISIS PHARMA GmbH, Galileistr. 6, 08056, Zwickau, Deutschland

    Michael Stoeter (Referatsleiter Medizin) (Referatsleiter Medizin)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Dr. Dietrich Steinkopff Verlag, Darmstadt

About this paper

Cite this paper

Koch, B., Schiemann, AL., Stimpel, M. (1998). Klinische Evaluation des neuen ACE-Hemmers Moexipril in der Behandlung der arteriellen Hypertonie. In: Scholze, J., Stoeter, M. (eds) Bluthochdruck nach der Menopause. Steinkopff. https://doi.org/10.1007/978-3-642-93699-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93699-9_4

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1124-8

  • Online ISBN: 978-3-642-93699-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation